More recently, GOLPH2 was found upregulated in the serum of patients with hepatocellular carcinoma (HCC) compared with healthy individuals and has been proposed as a new serum marker of HCC, which is more sensitive than α-fetoprotein (Block et al, 2005; Marrero et al, 2005). This evidence concerns the gene GOLM1 and hepatocellular carcinoma.